223 related articles for article (PubMed ID: 29690880)
1. Abnormal pulmonary function tests predict the development of radiation-induced pneumonitis in advanced non-small cell lung Cancer.
Torre-Bouscoulet L; Muñoz-Montaño WR; Martínez-Briseño D; Lozano-Ruiz FJ; Fernández-Plata R; Beck-Magaña JA; García-Sancho C; Guzmán-Barragán A; Vergara E; Blake-Cerda M; Gochicoa-Rangel L; Maldonado F; Arroyo-Hernández M; Arrieta O
Respir Res; 2018 Apr; 19(1):72. PubMed ID: 29690880
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal Evaluation of Lung Function in Patients With Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation Therapy.
Torre-Bouscoulet L; Arroyo-Hernández M; Martínez-Briseño D; Muñoz-Montaño WR; Gochicoa-Rangel L; Bacon-Fonseca L; Pérez-Padilla R; Vergara E; García-Sancho C; Lozano-Ruiz F; Fernández-Plata R; Guzmán-Barragán A; Arrieta O
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):910-918. PubMed ID: 29976503
[TBL] [Abstract][Full Text] [Related]
3. Severity of radiation pneumonitis, from clinical, dosimetric and biological features: a pilot study.
Aso S; Navarro-Martin A; Castillo R; Padrones S; Castillo E; Montes A; Martínez JI; Cubero N; López R; Rodríguez L; Palmero R; Manresa F; Guerrero T; Molina M
Radiat Oncol; 2020 Oct; 15(1):246. PubMed ID: 33109238
[TBL] [Abstract][Full Text] [Related]
4. Change in diffusing capacity after radiation as an objective measure for grading radiation pneumonitis in patients treated for non-small-cell lung cancer.
Lopez Guerra JL; Gomez D; Zhuang Y; Levy LB; Eapen G; Liu H; Mohan R; Komaki R; Cox JD; Liao Z
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1573-9. PubMed ID: 22768989
[TBL] [Abstract][Full Text] [Related]
5. Acute severe radiation pneumonitis among non-small cell lung cancer (NSCLC) patients with moderate pulmonary dysfunction receiving definitive concurrent chemoradiotherapy: Impact of pre-treatment pulmonary function parameters.
Zhou Y; Yan T; Zhou X; Cao P; Luo C; Zhou L; Xu Y; Liu Y; Xue J; Wang J; Wang Y; Lu Y; Liang B; Gong Y
Strahlenther Onkol; 2020 Jun; 196(6):505-514. PubMed ID: 31828393
[TBL] [Abstract][Full Text] [Related]
6. Poor baseline pulmonary function may not increase the risk of radiation-induced lung toxicity.
Wang J; Cao J; Yuan S; Ji W; Arenberg D; Dai J; Stanton P; Tatro D; Ten Haken RK; Wang L; Kong FM
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):798-804. PubMed ID: 22836048
[TBL] [Abstract][Full Text] [Related]
7. No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early- stage peripheral non-small cell lung cancer: an analysis of RTOG 0236.
Stanic S; Paulus R; Timmerman RD; Michalski JM; Barriger RB; Bezjak A; Videtic GM; Bradley J
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1092-9. PubMed ID: 24661663
[TBL] [Abstract][Full Text] [Related]
8. Changes in pulmonary function after three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, or proton beam therapy for non-small-cell lung cancer.
Lopez Guerra JL; Gomez DR; Zhuang Y; Levy LB; Eapen G; Liu H; Mohan R; Komaki R; Cox JD; Liao Z
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e537-43. PubMed ID: 22420964
[TBL] [Abstract][Full Text] [Related]
9. Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer.
Mayahara H; Uehara K; Harada A; Kitatani K; Yabuuchi T; Miyazaki S; Ishihara T; Kawaguchi H; Kubota H; Okada H; Ninomaru T; Shindo C; Hata A
Radiat Oncol; 2022 Jan; 17(1):7. PubMed ID: 35033139
[TBL] [Abstract][Full Text] [Related]
10. Impact of 3D conformal radiotherapy on lung function of patients with lung cancer: a prospective study.
Enache I; Noel G; Jeung MY; Meyer N; Oswald-Mammosser M; Pistea C; Jung GM; Mennecier B; Quoix E; Charloux A
Respiration; 2013; 86(2):100-8. PubMed ID: 23154264
[TBL] [Abstract][Full Text] [Related]
11. Role of perfusion SPECT in prediction and measurement of pulmonary complications after radiotherapy for lung cancer.
Farr KP; Kramer S; Khalil AA; Morsing A; Grau C
Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1315-24. PubMed ID: 25862455
[TBL] [Abstract][Full Text] [Related]
12. Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
Hayashi K; Yamamoto N; Karube M; Nakajima M; Matsufuji N; Tsuji H; Ogawa K; Kamada T
Radiat Oncol; 2017 May; 12(1):91. PubMed ID: 28558766
[TBL] [Abstract][Full Text] [Related]
13. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03.
Hartsell WF; Scott CB; Dundas GS; Mohiuddin M; Meredith RF; Rubin P; Weigensberg IJ
Am J Clin Oncol; 2007 Aug; 30(4):368-76. PubMed ID: 17762437
[TBL] [Abstract][Full Text] [Related]
14. Patient-reported lung symptoms as an early signal of impending radiation pneumonitis in patients with non-small cell lung cancer treated with chemoradiation: an observational study.
Yue J; Shi Q; Xu T; Jeter M; Chen TY; Komaki R; Gomez DR; Pan T; Cleeland CS; Liao Z; Wang XS
Qual Life Res; 2018 Jun; 27(6):1563-1570. PubMed ID: 29549533
[TBL] [Abstract][Full Text] [Related]
15. Symptomatic Radiation Pneumonitis in NSCLC Patients Receiving EGFR-TKIs and Concurrent Once-daily Thoracic Radiotherapy: Predicting the Value of Clinical and Dose-volume Histogram Parameters.
Yang X; Mei T; Yu M; Gong Y
Zhongguo Fei Ai Za Zhi; 2022 Jun; 25(6):409-419. PubMed ID: 35747920
[TBL] [Abstract][Full Text] [Related]
16. Endostar acts as a pneumonitis protectant in patients with locally advanced non-small cell lung cancer receiving concurrent chemoradiotherapy.
Chen K; Li S; Chen M; Jin Z; Sun X; Zhou S; Yang H
BMC Cancer; 2024 Feb; 24(1):257. PubMed ID: 38395838
[TBL] [Abstract][Full Text] [Related]
17. Combined analysis of V20, VS5, pulmonary fibrosis score on baseline computed tomography, and patient age improves prediction of severe radiation pneumonitis after concurrent chemoradiotherapy for locally advanced non-small-cell lung cancer.
Tsujino K; Hashimoto T; Shimada T; Yoden E; Fujii O; Ota Y; Satouchi M; Negoro S; Adachi S; Soejima T
J Thorac Oncol; 2014 Jul; 9(7):983-990. PubMed ID: 24922010
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: a prospective study.
Ferrero C; Badellino S; Filippi AR; Focaraccio L; Giaj Levra M; Levis M; Moretto F; Torchio R; Ricardi U; Novello S
Lung Cancer; 2015 Sep; 89(3):350-6. PubMed ID: 26164208
[TBL] [Abstract][Full Text] [Related]
19. Optimizing lung cancer radiation therapy: A systematic review of multifactorial risk assessment for radiation-induced lung toxicity.
Bensenane R; Helfre S; Cao K; Carton M; Champion L; Girard N; Glorion M; Vieira T; Waissi W; Crehange G; Beddok A
Cancer Treat Rev; 2024 Mar; 124():102684. PubMed ID: 38278078
[TBL] [Abstract][Full Text] [Related]
20. Changes in Pulmonary Function Following Image-Guided Stereotactic Lung Radiotherapy: Neither Lower Baseline Nor Post-SBRT Pulmonary Function Are Associated with Worse Overall Survival.
Stone B; Mangona VS; Johnson MD; Ye H; Grills IS
J Thorac Oncol; 2015 Dec; 10(12):1762-9. PubMed ID: 26334751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
